Metropolitan Hematology/Oncology Medical Group, Inc.

Los Angeles, California 90057

0 studies enrolling now · 1 studies all time

What they study most

Pancreatic Cancer

Studies at this site

• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed